Antistoffer hos patienter med kronisk inflammatorisk demyeliniserende polyneuropati

Abdullahi Mohamed, Thomas Krøigård, Thomas Agerbo Gaist, Lars Kjøbsted Markvardsen, Søren Sindrup, Henning Andersen, Morten Blaabjerg

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Abstract

Recent studies have identified specific immunoglobulin (Ig) G4 antibodies against the paranodal proteins neurofascin 155 and contactin 1 in subgroups of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). These patients present with distinct clinical phenotypes and poor response to first-line therapy with intravenous Ig. Detection of these antibodies in patients with CIDP has diagnostic, prognostic, and therapeutic implications. This review summarises the current knowledge on clinical characteristics, pathogenesis and treatment of these patients.

Bidragets oversatte titelAntibodies in patients with chronic inflammatory demyelinating polyneuropathy
OriginalsprogDansk
ArtikelnummerV08180526
TidsskriftUgeskrift for Læger
Vol/bind180
ISSN0041-5782
StatusUdgivet - 3 dec. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Antistoffer hos patienter med kronisk inflammatorisk demyeliniserende polyneuropati'. Sammen danner de et unikt fingeraftryk.

Citationsformater